Abstract
Ventilator-associated pneumonia (VAP) is a common complication in intubated and mechanically ventilated patients. A tracheostomy has been suggested to benefit patients with prolonged need for mechanical ventilation and may protect against VAP. However, a causal relationship between tracheostomy and VAP has also been suggested. This manuscript reviews the literature regarding the (causal) relationship between tracheostomy and VAP in adult critically ill patients.
Keywords: Ventilator associated pneumonia, tracheostomy, risk factors, timing, outcome
Current Respiratory Medicine Reviews
Title: Tracheostomy - Causative or Preventive for Ventilator-Associated Pneumonia?
Volume: 6 Issue: 1
Author(s): Denise P. Veelo, Jan M. Binnekade and Marcus J. Schultz
Affiliation:
Keywords: Ventilator associated pneumonia, tracheostomy, risk factors, timing, outcome
Abstract: Ventilator-associated pneumonia (VAP) is a common complication in intubated and mechanically ventilated patients. A tracheostomy has been suggested to benefit patients with prolonged need for mechanical ventilation and may protect against VAP. However, a causal relationship between tracheostomy and VAP has also been suggested. This manuscript reviews the literature regarding the (causal) relationship between tracheostomy and VAP in adult critically ill patients.
Export Options
About this article
Cite this article as:
Veelo P. Denise, Binnekade M. Jan and Schultz J. Marcus, Tracheostomy - Causative or Preventive for Ventilator-Associated Pneumonia?, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820476
DOI https://dx.doi.org/10.2174/157339810790820476 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Current Pharmaceutical Design Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design Investigation of Human Papilloma Virus Associated with Oral Cancer with an Insight into Diagnostic Approaches and Recent Patents
Recent Patents on Biomarkers Radiation Oncology and Molecular-Targeted Therapy for EGFR and its Signal Transduction Pathways: Molecular Basis and Clinical Application for Improvement of Radiotherapeutic Outcomes
Current Signal Transduction Therapy HER2 in the Era of Molecular Medicine: A Review
Current Cancer Therapy Reviews Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
Current Cancer Therapy Reviews Poly(ADP-ribosylation) and Neoplastic Transformation: Effect of PARP Inhibitors
Current Pharmaceutical Biotechnology Syntheses and Preliminary Evaluation of Dual Target PET Probe [<sup>18</sup>F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Epigenetics and Sjogren’s Syndrome
Current Pharmaceutical Biotechnology Adenosine and the Auditory System
Current Neuropharmacology Telomerase Inhibitors: Potential Anticancer Agents
Mini-Reviews in Organic Chemistry New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Cell Cycle as a Target of Antineoplastic Drugs
Current Pharmaceutical Design Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design Non-Melanoma Skin Cancer – Overview
Current Cancer Therapy Reviews Bcl-2 Family Proteins as Therapeutic Targets
Current Pharmaceutical Design Pain Biomarkers in Cancer: An Overview
Current Pharmaceutical Design Pre-therapy Iodine-131 Uptake Value as a Prediction Method for Metastatic Lymph Node Status in Patients with Differentiated Thyroid Carcinoma
Current Medical Imaging